Trials / Sponsors / Abfero Pharmaceuticals, Inc
Abfero Pharmaceuticals, Inc
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | SP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare Anemias Iron Overload, Beta-Thalassemia | Phase 2 | 2020-08-01 |